Arrow Pharma acquires Australian operations of Amneal Pharma

Arrow Pharmaceuticals is a subsidiary of Strides Pharma Global Pte Ltd, Singapore, it added.Arrow Pharmaceuticals is really a subsidiary of Strides Pharma Global Pte Limited, Singapore, it added.
NEW DELHI: Drug firm Strides Shasun today stated its arm Arrow Pharmaceuticals has acquired Australian operations of Amneal Pharmaceuticals for any total thought on AUD 17 million (over Rs 85 crore).

The purchase would accelerate Arrow’s market achieve and can assist in attaining a leadership position within the Australian generics market, Strides Shasun stated inside a statement.

Underneath the the agreement, Arrow Pharmaceuticals will acquire 100 percent from the issued capital of Amneal Pharmaceutical Pty Limited Australia, it added.

“Arrow will incur some AUD 17 million towards consideration, capital along with other believed acquisition and integration related costs,” Strides Shasun stated.

Arrow Pharmaceuticals is really a subsidiary of Strides Pharma Global Pte Limited, Singapore, it added.

Commenting around the development, Arrow Pharmaceuticals Chairman Dennis Bastas stated: “The purchase of Amneal’s Australian operations further expands our customer footprint.”

Getting Amneal’s subscriber base in to the network of supporting pharmacies further accelerates the present growth and strengthens the offering the organization provide its customers, he added.

Shares of Strides Shasun today closed at Rs 908.45 per scrip on BSE, lower .53 percent in the previous close.

Leave a Reply

Your email address will not be published. Required fields are marked *